We have developed a new ââ?¬Å?drugââ?¬Â and approach that appear to be effective in reducing arterial age. This ââ?¬Å?drugââ?¬Â represents a\nlow, subtherapeutic dose of statin and sartan and particularly their low-dose combination. The improvement of arterial wall\ncharacteristics, also reflecting in a decrease of arterial age, was achieved after a short period of treatment (one month) with the\nabove-mentioned drugs. In addition, we have also implemented a new, innovative therapeutic approach, consisting of intermittent\n(cyclic) treatmentââ?¬â?alternating short ââ?¬Å?treatmentââ?¬Â periods andmuch longer ââ?¬Å?restââ?¬Â periods (when the beneficial effects are still present\nbut gradually decline). This new ââ?¬Å?drugââ?¬Â and approach both merit further investigation in order to confirm their antiaging efficacy.
Loading....